BRCA1 and cancer: The United Kingdom Biobank study analysis found that the average cancer risk appeared to be lower in germline carriers in the biobank as compared to the BRCA1/2 carriers with a positive family history, suggesting that the nature of the variant and/or the genetic background modifies risk [82].